Advanced Biomed Inc. Common Stock cash flow to debt ratio of -5.75K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Advanced Biomed Inc. Common Stock's free cash flow has decreased 967.11% from $-182.45K last year to $-1.95M, signaling decreasing performance

Advanced Biomed Inc. Common Stock's debt to equity ratio is 0.05, which means that the company's assets are healthy financed, signaling financial stability.

Advanced Biomed Inc. Common Stock's debt has decreased relative to shareholder equity from 0.36 last year to 0.05 today, signaling strengthened financials

Advanced Biomed Inc. Common Stock has a net cash position, so leverage is healthy.

Advanced Biomed Inc. Common Stock's interest coverage ratio is -892.87, which means that the company struggles to meet interest obligations, signaling financial risk.

Advanced Biomed Inc. Common Stock has insufficient data to evaluate this check.

Advanced Biomed Inc. Common Stock's short-term assets of $13.75M exceed its short-term liabilities of $1.47M

Advanced Biomed Inc. Common Stock's return on assets of 48.56% is higher than the 5.00% threshold, indicating efficient asset utilization

Advanced Biomed Inc. Common Stock's return on equity of 122.03%, is higher than 15.00%, indicating good performance

Advanced Biomed Inc. Common Stock's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Advanced Biomed Inc. Common Stock has insufficient public price history to evaluate earnings stability.

Advanced Biomed Inc. Common Stock has negative free cash flow, indicating the company is burning cash rather than generating it

Advanced Biomed Inc. Common Stock has negative free cash flow, indicating cash burn

Advanced Biomed Inc. Common Stock's yearly earnings has increased 304.88% since last year from $-3.26M to $6.68M, signaling increasing performance

Advanced Biomed Inc. Common Stock's yearly revenue has increased % since last year from $0.00 to $127.64K, signaling increasing performance

ROIC -49.38% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Advanced Biomed Inc. Common Stock has insufficient revenue history to calculate 3-year revenue CAGR.

Advanced Biomed Inc. Common Stock has insufficient public price history to evaluate revenue consistency.

Advanced Biomed Inc. Common Stock has insufficient public price history to evaluate ROE consistency.

Advanced Biomed Inc. Common Stock has insufficient data to evaluate this check.

Advanced Biomed Inc. Common Stock has an earnings yield of 23.64%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Advanced Biomed Inc. Common Stock is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Advanced Biomed Inc. Common Stock has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Advanced Biomed Inc. Common Stock has insufficient data to evaluate this check.

Advanced Biomed Inc. Common Stock had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.

Advanced Biomed Inc. Common Stock has a price-to-book ratio of 0.20x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Advanced Biomed Inc. Common Stock has a price-to-sales ratio of 19.43x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue